Michaelson Jennifer — SEC Form 4 filings
SEC reporting owner CIK 1838061. 26 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2024-02-23 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 28 legs across 22 filings — 200,221 shares, $3,992,296 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 37,723 shares @ $27.82 ($1,049,454) in Cullinan Therapeutics, Inc., filed 2024-05-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | Chief Scientific Officer | 26 | — | 28 legs · 200,221 sh · $3,992,296 | 23 |
Form 4 filings — Michaelson Jennifer
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Option exercise (M): 4,000 @ $4.30 · Sale (S): 8,000 @ $21.57 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Option exercise (M): 30,000 @ $4.30 · Sale (S): 30,000 @ $20.26 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Option exercise (M): 4,000 @ $4.30 · Sale (S): 8,000 @ $17.82 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-05-06 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Option exercise (M): 4,000 @ $4.30 · Sale (S): 7,800 @ $14.60 · Sale (S): 200 @ $15.58 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Option exercise (M): 4,000 @ $4.30 · Sale (S): 8,000 @ $15.68 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 1,780 @ $14.14 | EDGAR |
| 2026-02-25 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 1,752 @ $13.99 · Sale (S): 3,601 @ $14.47 | EDGAR |
| 2026-02-23 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 3,742 @ $13.62 · Option exercise (M): 8,000 @ $4.30 · Sale (S): 8,000 @ $14.30 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 57,500 @ $0 · Grant/award (A): 115,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 416 @ $12.03 | EDGAR |
| 2026-01-23 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 4,000 @ $12.30 | EDGAR |
| 2025-12-22 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 1,345 @ $10.01 | EDGAR |
| 2025-12-19 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 2,898 @ $9.67 | EDGAR |
| 2025-12-16 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 2,148 @ $12.38 · Sale (S): 995 @ $11.90 | EDGAR |
| 2025-11-25 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 4,000 @ $12.30 | EDGAR |
| 2025-02-27 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 3,756 @ $8.53 | EDGAR |
| 2025-02-21 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 4,000 @ $12.51 | EDGAR |
| 2024-12-20 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 4,693 @ $11.41 | EDGAR |
| 2024-12-16 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 3,489 @ $12.52 | EDGAR |
| 2024-11-07 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 8,000 @ $15.64 | EDGAR |
| 2024-09-09 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 8,000 @ $18.09 | EDGAR |
| 2024-07-09 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Sale (S): 8,000 @ $16.33 | EDGAR |
| 2024-07-02 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 2,360 @ $9 | EDGAR |
| 2024-05-08 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Option exercise (M): 50,000 @ $4.30 · Sale (S): 37,723 @ $27.82 · Sale (S): 20,277 @ $28.54 · Option exercise (M): 5,606 @ $4.30 · Sale (S): 5,606 @ $30.06 · Option exercise (M): 50,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-23 | 4 | Cullinan Oncology, Inc. (CGEM) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1838061 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →